Related Experiment Video
Updated: Feb 25, 2026

Dual-Dye Optical Mapping of Hearts from RyR2R2474S Knock-In Mice of Catecholaminergic Polymorphic Ventricular Tachycardia
Published on: December 22, 2023
Catecholaminergic Polymorphic Ventricular Tachycardia
Nicola Monteforte1, Marina Cerrone2
1Molecular Cardiology Laboratories, Fondazione S. Maugeri IRCCS, via Maugeri 10/10A, Pavia 27100, Italy.
Insights
Catecholaminergic polymorphic ventricular tachycardia (CPVT) is a genetic heart condition causing dangerous arrhythmias due to calcium issues. Research is advancing our understanding of its mechanisms and leading to new treatments for sudden cardiac death.
Area of Science:
- Cardiology
- Genetics
- Molecular Biology
Background:
- Catecholaminergic polymorphic ventricular tachycardia (CPVT) is a life-threatening inherited arrhythmia syndrome.
- It is characterized by a structurally normal heart and high early-childhood lethality.
- Genetic discoveries revealed intracellular calcium dysregulation as the primary cause of CPVT arrhythmias.
Purpose of the Study:
- To review the clinical and genetic features of CPVT.
- To highlight pathophysiologic insights from experimental research.
- To discuss future therapeutic targets for CPVT.
Main Methods:
- Review of clinical and genetic data in CPVT.
- Analysis of experimental research on arrhythmogenesis.
- Exploration of therapeutic strategies.
Main Results:
- Significant progress in understanding CPVT molecular mechanisms.
- Insights into calcium dysregulation's role in arrhythmias.
- Identification of potential new therapeutic targets.
Conclusions:
- CPVT research has implications beyond inherited arrhythmias, informing conditions like heart failure.
- Experimental findings are guiding the development of novel therapies.
- Future strategies aim to reduce sudden death incidence in CPVT patients.
Abstract:
Catecholaminergic polymorphic ventricular tachycardia (CPVT) is an inherited arrhythmogenic disease characterized by a structurally normal heart and high lethality beginning in early childhood. The identification of its genetic bases made possible the discovery that arrhythmias are caused by intracellular calcium dysregulation. In the 9 years since the description of the genetic substrate of the disease, we have witnessed remarkable progress in the unraveling of the molecular mechanisms underlying its arrhythmogenesis. The impact of these discoveries extends beyond the field of inherited arrhythmias and sheds new light on the arrhythmogenic mechanisms in some more prevalent diseases characterized by abnormal calcium regulation, such as heart failure. Additionally, basic research studies led to the exploration of new therapeutic strategies with potential clinical impact in the near future in reducing the still high incidence of sudden death associated with these conditions. In the current review, the authors discuss the clinical and genetic features of CPVT, highlighting pathophysiologic insights derived from experimental research and future therapeutic targets.
More Related Videos
06:57Ablation of Ischemic Ventricular Tachycardia Using a Multipolar Catheter and 3-dimensional Mapping System for High-density Electro-anatomical Reconstruction
Published on: January 31, 2019
08:05Optimization of Transesophageal Atrial Pacing to Assess Atrial Fibrillation Susceptibility in Mice
Published on: June 29, 2022
Related Concept Videos
Dysrhythmias III: Characteristics of Dysrhythmias
ECG Interpretation of Arrhythmias II: Atrial, Junctional and Ventricular Arrhythmias
Dysrhythmias II: Classification of Tachyarrhythmias
Disturbances in Heart Rhythm
Arrhythmias are categorized by their speed, rhythm, and origin. A slow heart...
Dysrhythmias IV: Characteristics of Bradyarrhythmias
Cardiomyopathy I: Introduction and Classification